Active Not Recruiting OBSERVATIONAL NCT06564870
Efficacy and Safety Study of DURVALUMAB Maintenance in Patients With Stage III Non-Small Cell Lung Cancer (DURVABREIZH)
Retrospective Observational Study of the Efficacy and Safety of DURVALUMAB Maintenance Therapy in Patients With Stage III Non-Small Cell Lung Cancer (DURVABREIZH)
Sponsor: University Hospital, Brest
Conditions
Bronchial Cancer
Updated 1 time since 2024 Last updated: Aug 19, 2024 Started: Jun 1, 2021 Primary completion: Jun 30, 2023 Completion: Dec 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This observational or N/A phase trial investigates Bronchial Cancer and is currently ongoing. University Hospital, Brest leads this study, which shows 1 recorded version since 2021 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
1 version recorded Active Not Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- University Hospital, Brest
Data source: University Hospital, Brest
For direct contact, visit the study record on ClinicalTrials.gov .